MSCs are recruited at the tumor site in response to various chemokines, such as CCL2 or CXCL12, secreted by CD133+ tumor stem cells, as demonstrated in mice bearing glioblastomas [34]. The gene discussed is PROM1; the disease is glioblastoma.